XML 56 R46.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Convertible Note Payable (Details) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3 Months Ended | 6 Months Ended
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Jun. 17, 2024 USD ($) $ / shares shares | May 23, 2024 USD ($) | May 21, 2024 shares | May 20, 2024 USD ($) $ / shares | Apr. 19, 2024 shares | Apr. 17, 2024 USD ($) $ / shares | Apr. 03, 2024 shares | Apr. 02, 2024 USD ($) $ / shares | Feb. 21, 2024 shares | Feb. 16, 2024 USD ($) $ / shares | Feb. 05, 2024 shares | Feb. 01, 2024 USD ($) $ / shares | Jan. 16, 2024 shares | Jan. 11, 2024 USD ($) $ / shares | Apr. 13, 2023 USD ($) | Apr. 19, 2022 $ / shares | Nov. 19, 2021 $ / shares | Jun. 30, 2024 USD ($) $ / shares | Jun. 30, 2023 USD ($) | Jun. 30, 2024 USD ($) $ / shares shares | Jun. 30, 2023 USD ($)
Convertible Note Payable [line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Debt extension fee (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 65,639 |  |  |  |  |  |
Note and accrued interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2.00% |  |  |  |  |  |
Debt redemptions weighted average price |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 82.00% |
Number of trading days | 10 days |  |  | 10 days |  | 10 days |  | 10 days |  | 10 days |  | 10 days |  | 10 days | 10 days |  |  | 10 days |  | 10 days |
Extension fee |  | 2.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding balance of extension fee (in Dollars) |  | $ 10,934 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Description of interest accrued |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Interest accrues on the outstanding balance of the Note at 5% per annum compounded daily. Upon the occurrence of an Event of Default as defined in the Note, interest accrues at the lesser of 22% per annum or the maximum rate permitted by applicable law. In addition, upon any Event of Default, the Investor may accelerate the outstanding balance payable under the Note, which will increase automatically upon such acceleration by 15% or 5%, depending on the nature of the Event of Default. |
Redeem of outstanding note (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 500,000 |
Debt instrument redemption price percentage | 82.00% |  |  | 82.00% |  | 82.00% |  | 82.00% |  | 82.00% |  | 82.00% |  | 82.00% |  |  |  |  |  |  |
Note redeemable into shares (in Shares) | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,003,001 |
Weighted average price (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.2049 |
Debt redemption amount (in Dollars) | $ 150,000 |  |  | $ 150,000 |  | $ 150,000 |  | $ 150,000 |  | $ 150,000 |  | $ 150,000 |  | $ 150,000 |  |  |  |  |  |  |
Stock issued during period shares (in Shares) | shares | 701,918 |  | 590,783 |  | 540,735 |  | 512,470 |  | 408,164 |  | 402,685 |  | 380,228 |  |  |  |  |  |  |  |
Convertible Notes [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Convertible Note Payable [line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Note converted into common stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 70,000 | 176,229 |  |  | 2,736 |
Conversion price (in Dollars per share) | $ / shares | $ 0.2137 |  |  | $ 0.2539 |  | $ 0.2774 |  | $ 0.2927 |  | $ 0.3675 |  | $ 0.3725 |  | $ 0.3945 |  |  | $ 29.79085 | $ 150 |  | $ 150 |
Debt instrument redemption price percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 82.00% |
Interest expense (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 19,058 | $ 105,545 | $ 33,370 | $ 151,563
Debt redemption amount (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 150,000 |  |  |  |  |  |  |
Convertible Notes [Member] | China Pharma’s [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Convertible Note Payable [line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Note converted into common stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 35,000 |
Minimum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Convertible Note Payable [line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Debt redemptions weighted average price |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 85.00% |  |  |  |  |  |
Redemption amount (in Dollars) |  | 150,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Convertible Note Payable [line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Debt redemptions weighted average price |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 82.00% |  |  |  |  |  |
Redemption amount (in Dollars) |  | $ 37,182.33 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock [Member] | Convertible Notes [Member] | China Pharma’s [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Convertible Note Payable [line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion price (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 75 |  |  |  |  |

X
- Definition Percentage of extension fee. + References No definition available. + Details
Name: | cphi_ExtensionFee
Namespace Prefix: | cphi_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of interest accrues on Note. + References No definition available. + Details
Name: | cphi_InterestAccruesOnNoteDescription
Namespace Prefix: | cphi_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares redeemable by Notes. + References No definition available. + Details
Name: | cphi_NoteRedeemableIntoShares
Namespace Prefix: | cphi_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of trading days. + References No definition available. + Details
Name: | cphi_NumberOfTradingDays
Namespace Prefix: | cphi_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage of balance note and accrued interest. + References No definition available. + Details
Name: | cphi_PercentageOfBalanceNoteAndAccruedInterest
Namespace Prefix: | cphi_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of redeem of outstanding note. + References No definition available. + Details
Name: | cphi_RedeemOfOutstandingNote
Namespace Prefix: | cphi_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The redemption amount for outstanding balance. + References No definition available. + Details
Name: | cphi_RedemptionAmountForOutstandingBalance
Namespace Prefix: | cphi_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The weighted average price per share. + References No definition available. + Details
Name: | cphi_WeightedAveragePrice
Namespace Prefix: | cphi_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The price per share of the conversion feature embedded in the debt instrument. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5 + Details
Name: | us-gaap_DebtInstrumentConvertibleConversionPrice1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-7 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6 + Details
Name: | us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of the fee that accompanies borrowing money under the debt instrument. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_DebtInstrumentFeeAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Percentage price of original principal amount of debt at which debt can be redeemed by the issuer. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 470 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3 + Details
Name: | us-gaap_DebtInstrumentRedemptionPricePercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of principal amount of debt redeemed. + References No definition available. + Details
Name: | us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair value amount of debt instrument that was repurchased. + References No definition available. + Details
Name: | us-gaap_DebtInstrumentRepurchaseAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of the cost of borrowed funds accounted for as interest expense for debt. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(8)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69E -Publisher FASB -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69F -Publisher FASB -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1F -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6 + Details
Name: | us-gaap_InterestExpenseDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of cash outflow for fees classified as other. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (g) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25 + Details
Name: | us-gaap_PaymentsForFees
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ShortTermDebtLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_DebtInstrumentAxis=cphi_ConvertibleNotesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=cphi_ChinaPharmaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |